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1. Introduction 
The biosynthesis of bacterial cell wall peptido- 
glycan is a complex process involving cytoplasmic and 
membrane steps [l] . N-Acetylglucosaminyl-N-acetyl- 
muramyl-(pentapeptide)-pyrophosphoryl-undeca- 
prenol is the last membrane precursor prior to polym- 
erization which proceeds by transglycosylation 
(formation of the linear glycan strands) and transpep- 
tidation (crosslinking of the peptide subunits) [l] . 
This membrane intermediate has been utilized in cell- 
free systems for the formation of peptidoglycan 
[2-l] , but the difficulty in conveniently isolating it 
in adequate amounts has greatly limited the direct 
investigation of the polymerizing enzymes. Most 
commonly, the in vitro synthesis of peptidoglycan is 
carried out by incubating the cytoplasmic precursors, 
UDP-iV-acetylmuramyl-pentapeptide and UDP-N- 
acetylglucosamine, with appropriate particulate prep- 
arations, crude cell walls or treated cells [3-lo] (see 
[l] for ref. before 1972). Under these conditions 
only the over-all course of the different membrane 
reactions is considered. However, a study of each 
membrane step in itself is essential for the under- 
standing of the mode of action of certain antibiotics, 
for the development of the genetic analysis of these 
reactions and for the determination of the mechanisms 
involved in their regulation. Recently, the transpepti- 
dation step, uncoupled from the other membrane 
reactions, has been successfully studied with artificial 
systems of donor and acceptor peptides [ 1 ,111. As 
far as we are aware, the transglycosylation step has 
not yet been directly investigated to any extent. 
The present paper describes a convenient in vitro 
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assay specific for the transglycosylation reaction 
which promotes the formation of uncrosslinked pep- 
tidoglycan. The main features of the assay were the 
use of N-acetylglucosaminyl-N-acetylmuramyl-(penta- 
peptide)-pyrophosphoryl-undecaprenol as substrate, 
the use of particulate fraction from E. coli K12 in 
the presence of penicillin G, the high stimulating effect 
of 0.1% sodium deoxycholate and the inhibition by 
antibiotics such as 11837 R.P. and moenomycin. 
2. Materials and methods 
2.1. Preparation of the membrane precursor and of 
the particulate ji-action 
N-Acetylglucosaminyl-N-acetylmuramyl(penta- 
peptide)-pyrophosphoryl-undecaprenol containing 
D- [ 14C] alanine residues was prepared as in [ 121, 
slightly modified. The amino acid and hexosamine 
composition of the purified product (2.1 mCi/mmol) 
was: glutamic acid, 1; alanine, 2.7; diaminopimelic 
acid, 1; muramic acid, 0.9; glucosamine, 0.9. 
E. coli K12 HfrH was grown under strong aeration 
at 37’C in a 20 liter fermentor in the medium in [ 131. 
Cells were harvested at 1/3rd maximal growth, washed 
with 0.02 M Tris-HCl buffer, pH 8, and disrupted by 
grinding with alumina as in [ 141. The cell-alumina 
mixture was suspended in 0.05 M Tris-HCl buffer, 
pH 7.5, containing lo5 M 2-mercaptoethanol and 
lo4 M MgC!lz , centrifuged for 5 min at 10 000 X g. 
The supematant was centrifuged for 1 h at 
100 000 X g. The pellet was washed once with the 
same buffer, suspended at a protein concentration 
of 30 mg/ml and used as source of enzyme. 
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2.2. Enzymatic assay Table 1 
The assay for transglycosidase activity was per- 
formed by incubating at 30°C for 30 min 5 nmol 
r4C-labeled precursor (23 000 dpm) with 10 ~10.5 M 
Tris-HCl buffer, pH 7.5,3 ~10.1 M MgCl*, 5 pl 
0.25% penicillin G solution, 5 /_d 0.5% sodium deoxy- 
cholate solution and 5 /.d enzyme. The reaction 
products were separated by chromatography on 
Whatman no. 1 filter paper run overnight in isobutyric 
acid-l M ammonia (5:3). After localization with a 
47r Tracerlab scanner the radioactive spots were cut 
out and converted into 14C02 by combustion in an 
Oxymat apparatus (Intertechnique, Plaisir, 78, France). 
r4C02 was trapped in 18 ml solvent containing 7 g 
biphenyl-4-butyl-PBD[(biphenylyl-4)-2-(tert-butyl-4- 
phenyl)-5-oxadiazole-1,3,4] for 100 ml water, 220 ml 
methanol, 330 ml phenethylamine and 400 ml toluene. 
Samples were counted by liquid scintillation spectrom- 
etry. 
Effect of sodium deoxycholate and Triton X-100 on the 
transglycosylation reaction catalysing the formation of 
peptidoglycan 
Detergent added 
(final cont.) 
Membrane 
precursor 
(%) 
None 95 5 
Sodium deoxycholate (0.01%) 90 10 
Sodium deoxycholate (0.1%) 46 54 
Sodium deoxycholate (1%) 88 12 
Triton X-100 (0.01%) 86 14 
Triton X-100 (0.1%) 73 27 
Assays were carried out as in section 2. The appropriate 
amounts of detergent were added prior to the addition of 
enzyme. Values are expressed as % each compound as com- 
pared to the sum of both 
2.3. Digestion of the in vitro polymerized material by 
egg-white lysozyme 
The assay was scaled up 5-fold and the incubation 
prolonged for 1 h. After paper chromatography the 
polymerized material remaining at the origin was 
soaked with 0.1 M ammonium acetate (pH 6.5) con- 
taining 0.15% egg-white lysozyme and incubated 
overnight at 37°C in a screwed tube. By elution with 
water 90% of the radioactivity was recovered. The 
resulting degradation products were chromatographed 
on Whatman 3 MM filter paper run 3 days in n-butanol- 
acetic acid-water (4: 1: 5 ; upper phase) and compared 
with monomer and dimer peptidoglycan fragments of 
known structure [ 151. RF values were expressed with 
disaccharide tetrapeptide C6 taken as reference. 
to the assay so as to inhibit the transpeptidation step 
of polymerisation and the D-D-carboxypeptidase 
activity associated with the particulate fractions, 
which could catalyse the release of alanine (RF 0.60) 
from the membrane precursor or from the newly- 
formed peptidoglycan. The addition of detergents 
such as sodium deoxycholate or Triton X-100 greatly 
enhanced the amount of in vitro synthesized material 
(table 1). In pacticular, sodium deoxycholate at a 
final cont. 0.1% led to a lo-fold stimulation of the 
reaction. Under these conditions, the time course of 
formation of peptidoglycan was essentially linear for 
the first 30 min. After 1 h the formation of side- 
products still remained low and up to 65% of the 
membrane precursor could be converted into polym- 
erized material. 
3.2. Characterization of the in vitro synthesized 
peptidoglycan 
3. Results and discussion 
3.1, In vitro formation of peptidoglycan 
When N-acetylglucosaminyl-N-acetylmuramyl- 
(pentapeptide)pyrophosphoryl-undecaprenol was 
incubated with the particulate preparation from 
E. coli K12 HfrH in the absence of detergent and 
the mixture was analysed by paper chromatography, 
it appeared that about 5% of the membrane precursor 
had been converted into immobile polymerized 
material (table 1). In all cases penicillin G was added 
When the in vitro polymerized material was 
digested with lysozyme and the degradation products 
analysed by paper chromatography, essentially one 
component (RF 1.07) accounting for 90% of the 
digested material was encountered. No well defined 
fragment of lower RF value (dimer or oligomer) was 
detectable and the residual radioactivity in this region 
was estimated at 3% of the solubilized material. A 
faster moving component (RF 1.50) was detected and 
accounted for 5% of all the radioactivity. 
The main component (RF 1.07) was further puri- 
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tied by paper electrophoresis and its composition was 
determined: alanine, 3; glutamic acid, 1; diamino- 
pimelic acid, 1; muramic acid, 1; glucosamine, 1. 
Furthermore, it had the same electrophoretic mobility 
at pH 2 as monomer C6 [ 151. These results showed 
that it was presumably the disaccharide pentapeptide 
monomer. Since lysozyme digestion yielded mainly 
this fragment, it was concluded that uncrosslinked 
peptidoglycan was formed and that the assay was 
specific for the transglycosylation reaction. Our 
material thus resembled the soluble peptidoglycan 
synthesized from the nucleotide precursors under 
other conditions [3,8,9,16]. The length of the glycan 
strands and the nature of the reducing ends are now 
being examined. 
3.3. Effect of antibiotics 
Several antibiotics known to interfere with the 
biosynthesis of peptidoglycan were tested (table 2). 
Table 2 
Effects of antibiotics on the transglycosylation reaction 
catalysing the formation of peptidoglycan 
Antibiotic added Final cont. 
(rg/ml) 
% Inhibition 
The results obtained with ristocetin and vancomycin 
were similar to [3] for another system from E. coli. 
Compound 11837 R.P. [ 171 and moenomycin 
[ 181 were the best inhibitor of the reaction since 
they hadIDs,, values from 0.01-0.1 pg/ml. They thus 
most probably interact with the transglycosidase 
itself and not with the substrate. They interfered with 
the biosynthesis of peptidoglycan. [l&-20] and it 
had been speculated [21] that moenomycin might 
inhibit the elongation of the glycan chains. MIC values 
from 8-250 pg/ml were reported when moenomycin 
and 11837 R.P. were tested on E. coli [22] . These 
high values are presumably due to difficulties of 
penetration. With gram-positive bacteria MIC values 
from 0.005-0.3 pg/ml were found [22]. The inhibi- 
tion of the transglycosylation reaction by these anti- 
biotics is thus probably the main mechanism respon- 
sible for their antibacterial activity. Moenomycin and 
11837 R.P. will undoubtly be useful tools for the 
further investigation of the transglycosylation step 
and of the other membrane reactions involved in the 
biosynthesis of peptidoglycan. 
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